Pharmacogenomic Effect/ADR for Cevimeline (DBSNPE004597)

Identifier
DBSNPE004597
Drug
Cevimeline (DB00185)
Interacting Gene/Enzyme
Cytochrome P450 2D6
Gene Name
CYP2D6
UniProt ID
P10635
Defining Change(s)
3201C>Trs72549347
Allele Name
CYP2D6*56
Genotype(s)
Not Available
Type(s)
Effect Inferred
Groups
Non-functional CYP2D6
Description
Poor metabolizer, more adverse reactions.
References
  1. Evoxac® capsules (cevimeline hydrochloride)[package insert]. Montvale, New Jersey: Daiichi Pharmaceutical Corporation; 2006. [Link]